kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
JP Stock MarketDetailed Quotes
6331 Mitsubishi Kakoki Kaisha
- 3800
- +55+1.47%
20min DelayMarket Closed Feb 18 15:30 JST
30.07BMarket Cap5.36P/E (Static)
3805High3745Low35.20KVolume3745Open3745Pre Close133.03MTurnover448552wk High0.57%Turnover Ratio7.91MShares286152wk Low477.38EPS TTM23.30BFloat Cap6630Historical High5.36P/E (Static)6.13MShs Float850Historical Low708.69EPS LYR1.60%Amplitude130.00Dividend TTM0.79P/B100Lot Size3.42%Div YieldTTM
Mitsubishi Kakoki Kaisha Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.66%14.69B | 29.22%11.94B | 7.14%47.77B | 2.57%13.55B | 18.67%12.08B | 5.38%12.9B | 3.19%9.24B | -1.87%44.59B | -2.12%13.22B | -3.44%10.18B |
| Cost of revenue | 22.96%11.57B | 26.93%9.1B | 1.39%36.41B | -5.05%10.61B | 11.15%9.41B | 0.81%9.23B | 0.65%7.17B | -3.25%35.92B | 4.98%11.18B | -7.23%8.46B |
| Gross profit | 17.05%3.12B | 37.09%2.85B | 30.95%11.36B | 44.47%2.94B | 55.75%2.67B | 18.93%3.68B | 13.07%2.08B | 4.32%8.67B | -28.67%2.04B | 21.06%1.71B |
| Operating expense | 14.29%1.76B | 0.34%1.75B | 12.90%6.94B | 13.28%1.83B | 1.85%1.54B | 19.79%1.83B | 16.62%1.74B | 11.08%6.15B | 6.97%1.61B | 12.25%1.51B |
| Staff costs | ---- | ---- | 6.37%2.49B | ---- | ---- | ---- | ---- | 11.86%2.34B | ---- | ---- |
| Selling and administrative expenses | ---- | ---- | -0.13%1.57B | ---- | ---- | ---- | ---- | 15.79%1.57B | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | -5.17%257M | ---- | ---- | ---- | ---- | 29.05%271M | ---- | ---- |
| -General and administrative expense | ---- | ---- | 0.92%1.31B | ---- | ---- | ---- | ---- | 13.36%1.3B | ---- | ---- |
| Research and development costs | ---- | ---- | 116.67%598M | ---- | ---- | ---- | ---- | 20.00%276M | ---- | ---- |
| Depreciation and amortization | ---- | ---- | -2.10%140M | ---- | ---- | ---- | ---- | 34.91%143M | ---- | ---- |
| -Depreciation | ---- | ---- | -2.10%140M | ---- | ---- | ---- | ---- | 34.91%143M | ---- | ---- |
| Rent and land expenses | ---- | ---- | 8.88%184M | ---- | ---- | ---- | ---- | -17.16%169M | ---- | ---- |
| Other operating expenses | ---- | ---- | 18.90%1.96B | ---- | ---- | ---- | ---- | 6.65%1.65B | ---- | ---- |
| Operating profit | 20.83%1.36B | 227.38%1.1B | 74.87%4.42B | 163.36%1.11B | 461.19%1.13B | 18.09%1.84B | -2.33%336M | -9.13%2.53B | -68.57%423M | 195.59%201M |
| Net non-operating interest income (expenses) | 0.00%-7M | 0.00%-7M | 0.00%-29M | -16.67%-7M | 12.50%-7M | 0.00%-8M | 0.00%-7M | 3.33%-29M | 14.29%-6M | 0.00%-8M |
| Non-operating interest income | --0 | --0 | 0.00%1M | 0.00%1M | --0 | --0 | --0 | 0.00%1M | 0.00%1M | --0 |
| Non-operating interest expense | 0.00%7M | 0.00%7M | 0.00%30M | 14.29%8M | -12.50%7M | 0.00%8M | 0.00%7M | -3.23%30M | -12.50%7M | 0.00%8M |
| Net investment income | 36.29%338M | -11.22%261M | 2.11%485M | 86.89%114M | 259.42%248M | -968.75%-171M | -18.56%294M | -6.50%475M | -76.08%61M | -13.75%69M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 43.40%2.72B | -82.47%332M | 333.41%1.89B | 749.33%1.89B | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -151.00%-127M | -10.00%-33M | 132.28%143M | 80.49%-56M | 460.87%249M | 44.44%-20M | 41.18%-30M | -138.17%-443M | -258.75%-287M | -2,200.00%-69M |
| Less:Other special charges | 151.00%127M | 10.00%33M | -179.44%-143M | 133.33%56M | -460.87%-249M | -44.44%20M | -41.18%30M | 91.49%180M | -70.00%24M | 2,200.00%69M |
| Less:Write off | --0 | ---- | --0 | ---- | ---- | ---- | ---- | 185.87%263M | ---- | ---- |
| Other non-operating income (expenses) | 101.54%3M | -175.00%-11M | 1.89%-52M | 80.00%-1M | -19,400.00%-195M | 535.29%148M | 69.23%-4M | -210.42%-53M | 89.36%-5M | -100.98%-1M |
| Income before tax | -58.72%1.57B | 123.38%1.31B | 75.91%7.68B | -28.14%1.49B | 1,873.06%3.81B | 22.32%1.79B | -7.42%586M | 23.07%4.36B | 23.48%2.07B | -18.91%193M |
| Income tax | -53.84%523M | 169.66%391M | 72.50%2.28B | -37.84%368M | 582.53%1.13B | 71.00%631M | -24.87%145M | 23.60%1.32B | 53.37%592M | -20.57%166M |
| Net income | -60.79%1.05B | 107.94%917M | 77.36%5.4B | -24.32%1.12B | 9,807.41%2.68B | 5.93%1.16B | 0.23%441M | 22.90%3.04B | 14.55%1.48B | -6.90%27M |
| Net income continuous operations | -60.79%1.05B | 108.16%918M | 77.39%5.4B | -24.26%1.12B | 9,807.41%2.68B | 5.93%1.16B | 0.23%441M | 22.85%3.04B | 14.55%1.48B | -6.90%27M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -60.79%1.05B | 107.94%917M | 77.36%5.4B | -24.32%1.12B | 9,807.41%2.68B | 5.93%1.16B | 0.23%441M | 19.47%3.04B | 14.55%1.48B | -67.07%27M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -60.79%1.05B | 107.94%917M | 77.36%5.4B | -24.32%1.12B | 9,807.41%2.68B | 5.93%1.16B | 0.23%441M | 19.47%3.04B | 14.55%1.48B | -67.07%27M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -60.75%137.86 | 108.34%120.65 | 77.32%708.69 | -24.30%147.09 | 9,601.93%351.21 | 5.96%152.48 | 0.14%57.91 | 19.28%399.66 | 14.37%194.3 | -66.36%3.62 |
| Diluted earnings per share | -60.75%137.8483 | 108.34%120.65 | 77.32%708.69 | -24.32%147.0556 | 9,796.22%351.21 | 5.92%152.4338 | 0.14%57.91 | 19.28%399.66 | 14.41%194.3 | -67.02%3.5489 |
| Dividend per share | 0 | 0 | 37.50%110 | 0.00%80 | 0 | 30 | 0 | 14.29%80 | 14.29%80 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |